DNA RNA and Cells

18 Nov 2009 Alnylam Presents New Pre-clinical Data on ALN-VSP, an RNAi Therapeutic for the Treatment of Liver Cancer
18 Nov 2009 Aldagen Announces Clinical Data for ALD-201 for Ischemic Heart Failure Presented at AHA
17 Nov 2009 Study Meets Primary Endpoint with 25 Percent LDL Reduction in Very High-Risk Patient Population
16 Nov 2009 ReNeuron presents positive pre-clinical efficacy data with ReN009 stem cell therapy for peripheral arterial disease at leading US scientific conference
16 Nov 2009 Interim Results From Aastrom's IMPACT-DCM Cardiac Trial Presented at The American Heart Association Meeting
16 Nov 2009 Genta Announces Results of AGENDA Phase 3 Trial of GenasenseĀ® in Patients with Advanced Melanoma
16 Nov 2009 Phase 1/2 Results for Aldagen's ALD-301 Critical Limb Ischemia Clinical Study Presented at AHA
12 Nov 2009 Cequent Files its First IND with FDA: CEQ508, a tkRNAi Drug Candidate in Oncology
11 Nov 2009 Geron Collaborators Publish Data on hESC-Derived Glial Progenitor Cell Therapy in Cervical Spinal Cord Injury
11 Nov 2009 AMT Successful in Preclinical Treatment of DMD
11 Nov 2009 Aastrom to Initiate Second Phase II Clinical Trial for Treatment of Severe Chronic Heart Failure
10 Nov 2009 MOLOGEN applies for clinical study with cell-based gene therapy for renal cancer
09 Nov 2009 Zosano Pharma, Inc. Announces Publication of Positive Phase 2 Study of Its ZP-PTH Patch for Osteoporosis Therapy
06 Nov 2009 Genetix Pharmaceuticals Announces Global Clinical Plans to Treat Adrenoleukodystrophy (ALD)
06 Nov 2009 Oncolytics Biotech Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting
05 Nov 2009 Alnylam Presents New Pre-Clinical Data on RNAi Therapeutics at Oligonucleotides Therapeutics Society (OTS) Meeting
04 Nov 2009 Alnylam and Roche Advance RNAi Therapeutic Collaboration Phase of Landmark 2007 Alliance
04 Nov 2009 MOLOGEN reaches primary end points in MGN1703 study
03 Nov 2009 Idera Pharmaceuticals Presents Preclinical Data on IMO-2125, its Lead Drug Candidate for Chronic Hepatitis C Virus Infection, at Liver Meeting 2009
02 Nov 2009 Alnylam Presents New Pre-Clinical Data on ALN-TTR, an RNAi Therapeutic for the Treatment of Transthyretin-Mediated Amyloidosis
02 Nov 2009 NOXXON Announces Initiation of First-in-Human Clinical Trial with Hematopoietic Stem Cell Mobilizing SpiegelmerĀ® NOX-A12
29 Oct 2009 Heart Disease and Cellular Therapy: Start of Phase III Clinical Trial "PERFECT" Using Autologous CD133+ Bone Marrow Stem Cells
26 Oct 2009 AVI BioPharma Presents Updated Safety Data From Ongoing Systemic Trial of AVI-4658 at 7th Annual Action Duchenne International Conference
22 Oct 2009 Isis Pharmaceuticals Reports Positive Phase 2 Data for ISIS 113715 in Patients With Type 2 Diabetes

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up